Opinion: NEJM sheds light on payments to doctors

Forbes, June 11, 2013

It should come as no surprise that pharmaceutical companies pay doctors for a variety of reasons such as research, lecturing, and teaching. Such payments are justified as these physicians tend to be in demand as experts and their expertise is valued. They can't be expected to do this work pro bono – their time is valuable. However, such payments are viewed with great suspicion. Industry critics are quick to charge that what companies are really doing is currying favor with doctors so that they will write more prescriptions for their drugs. This type of "manipulation" is believed to be a conflict-of-interest.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.